Cockerell CJ. The pathology of melanoma. Dermatol Clin 2012; 30: 445-468.
Corazzari M, Fimia GM, Lovat P, Piacentini M. Why is autophagy important for melanoma? molecular mechanisms and therapeutic implications. Semin Cancer Biol 2013; 23: 337-343.
Fecher LA, Cummings SD, Keefe MJ, Alani RM. Toward a molecular classification of melanoma. J Clin Oncol 2007; 25: 1606-1620.
Arkenau HT, Kefford R, Long GV. Targeting BRAF for patients with melanoma. Br J Cancer 2011; 104: 392-398.
Soengas MS, Capodieci P, Polsky D, Mora J, Esteller M, Opitz-Araya X et al. Inactivation of the apoptosis effector apaf-1 in malignant melanoma. Nature 2001; 409: 207-211.
Tsao H, Goel V, Wu H, Yang G, Haluska FG. Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma. J Invest Dermatol 2004; 122: 337-341.
Ilmonen S, Hernberg M, Pyrhonen S, Tarkkanen J, Asko-Seljavaara S. Ki-67, bcl-2 and p53 expression in primary and metastatic melanoma. Melanoma Res 2005; 15: 375-381.
Wang YF, Jiang CC, Kiejda KA, Gillespie S, Zhang XD, Hersey P. Apoptosis induction in human melanoma cells by inhibition of MEK is caspase-independent and mediated by the bcl-2 family members PUMA, bim, and mcl-1. Clin Cancer Res 2007; 13: 4934-4942.
Jiang CC, Chen LH, Gillespie S, Wang YF, Kiejda KA, Zhang XD et al. Inhibition of MEK sensitizes human melanoma cells to endoplasmic reticulum stress-induced apoptosis. Cancer Res 2007; 67: 9750-9761.
Wellbrock C, Ogilvie L, Hedley D, Karasarides M, Martin J, Niculescu-Duvaz D et al. V599EB-RAF is an oncogene in melanocytes. Cancer Res 2004; 64: 2338-2342.
Martin S, Lamb HK, Brady C, Lefkove B, Bonner MY, Thompson P et al. Inducing apoptosis of cancer cells using small-molecule plant compounds that bind to GRP78. Br J Cancer 2013; 109: 433-443.
Flaherty KT, Infante JR, Daud A, Gonzalez R, Kefford RF, Sosman J et al. Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations. N Engl J Med 2012; 367: 1694-1703.
Cantwell-Dorris ER, O'Leary JJ, Sheils OM. BRAFV600E: Implications for carcinogenesis and molecular therapy. Mol Cancer Ther 2011; 10: 385-394.
Aguissa-Toure AH, Li G. Genetic alterations of PTEN in human melanoma. Cell Mol Life Sci 2012; 69: 1475-1491.
Dhomen N, Marais R. BRAF signaling and targeted therapies in melanoma. Hematol Oncol Clin North Am 2009; 23: 529-545 ix.
Lazova R, Klump V, Pawelek J. Autophagy in cutaneous malignant melanoma. J Cutan Pathol. 2010; 37: 256-268.
Ma XH, Piao S, Wang D, McAfee QW, Nathanson KL, Lum JJ et al. Measurements of tumor cell autophagy predict invasiveness, resistance to chemotherapy, and survival in melanoma. Clin Cancer Res 2011; 17: 3478-3489.
Armstrong JL, Corazzari M, Martin S, Pagliarini V, Falasca L, Hill DS et al. Oncogenic B-RAF signaling in melanoma impairs the therapeutic advantage of autophagy inhibition. Clin Cancer Res 2011; 17: 2216-2226.
Fimia GM, Piacentini M. Regulation of autophagy in mammals and its interplay with apoptosis. Cell Mol Life Sci 2010; 67: 1581-1588.
White E. Deconvoluting the context-dependent role for autophagy in cancer. Nat Rev Cancer 2012; 12: 401-410.
Hersey P, Zhang XD. Adaptation to ER stress as a driver of malignancy and resistance to therapy in human melanoma. Pigment Cell Melanoma Res 2008; 21: 358-367.
Rutkowski DT, Kaufman RJ. A trip to the ER: Coping with stress. Trends Cell Biol 2004; 14: 20-28.
Gorman AM, Healy SJ, Jager R, Samali A. Stress management at the ER: Regulators of ER stress-induced apoptosis. Pharmacol Ther 2012; 134: 306-316.
Verfaillie T, Salazar M, Velasco G, Agostinis P. Linking ER stress to autophagy: Potential implications for cancer therapy. Int J Cell Biol 2010; 2010: 930509.
Ma Y, Hendershot LM. The role of the unfolded protein response in tumour development: Friend or foe? Nat Rev Cancer 2004; 4: 966-977.
Rutkowski DT, Arnold SM, Miller CN, Wu J, Li J, Gunnison KM et al. Adaptation to ER stress is mediated by differential stabilities of pro-survival and pro-apoptotic mRNAs and proteins. PLoS Biol 2006; 4: E374.
Bernales S, McDonald KL, Walter P. Autophagy counterbalances endoplasmic reticulum expansion during the unfolded protein response. PLoS Biol 2006; 4: E423.
Corazzari M, Lovat PE. Harnessing autophagy for melanoma benefit. Cell Biol: Res Ther 2013; 2.
Maddodi N, Huang W, Havighurst T, Kim K, Longley BJ, Setaluri V. Induction of autophagy and inhibition of melanoma growth in vitro and in vivo by hyperactivation of oncogenic BRAF. J Invest Dermatol 2010; 130: 1657-1667.
Lovat PE, Corazzari M, Armstrong JL, Martin S, Pagliarini V, Hill D et al. Increasing melanoma cell death using inhibitors of protein disulfide isomerases to abrogate survival responses to endoplasmic reticulum stress. Cancer Res 2008; 68: 5363-5369.
Corazzari M, Lovat PE, Armstrong JL, Fimia GM, Hill DS, Birch-Machin M et al. Targeting homeostatic mechanisms of endoplasmic reticulum stress to increase susceptibility of cancer cells to fenretinide-induced apoptosis: The role of stress proteins ERdj5 and ERp57. Br J Cancer 2007; 96: 1062-1071.
Ma XH, Piao SF, Dey S, McAfee Q, Karakousis G, Villanueva J et al. Targeting ER stressinduced autophagy overcomes BRAF inhibitor resistance in melanoma. J Clin Invest 2014; 124: 1406-1417.
Nishitoh H, Matsuzawa A, Tobiume K, Saegusa K, Takeda K, Inoue K et al. ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats. Genes Dev 2002; 16: 1345-1355.
Bennett BL, Sasaki DT, Murray BW, O'Leary EC, Sakata ST, Xu W et al. SP600125, an anthrapyrazolone inhibitor of jun N-terminal kinase. Proc Natl Acad Sci U S A 2001; 98: 13681-13686.
He W, Wang Q, Srinivasan B, Xu J, Padilla MT, Li Z et al. A JNK-mediated autophagy pathway that triggers c-IAP degradation and necroptosis for anticancer chemotherapy. Oncogene 2013; 33: 3004-3013.
Pattingre S, Tassa A, Qu X, Garuti R, Liang XH, Mizushima N et al. Bcl-2 antiapoptotic proteins inhibit beclin 1-dependent autophagy. Cell 2005; 122: 927-939.
Yamamoto K, Ichijo H, Korsmeyer SJ. BCL-2 is phosphorylated and inactivated by an ASK1/jun N-terminal protein kinase pathway normally activated at G(2)/M. Mol Cell Biol 1999; 19: 8469-8478.
Salazar M, Carracedo A, Salanueva IJ, Hernández-Tiedra S, Egia A, Lorente M et al. TRB3 links ER stress to autophagy in cannabinoid anti-tumoral action. Autophagy 2009; 5: 1048-1049.
Salazar M, Carracedo A, Salanueva IJ, Hernández-Tiedra S, Lorente M, Egia A et al. Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells. J Clin Invest 2009; 119: 1359-1372.
Estrada Y, Dong J, Ossowski L. Positive crosstalk between ERK and p38 in melanoma stimulates migration and in vivo proliferation. Pigment Cell Melanoma Res 2009; 22: 66-76.
Ranganathan AC, Zhang L, Adam AP, Aguirre-Ghiso JA. Functional coupling of p38-induced up-regulation of BiP and activation of RNA-dependent protein kinase-like endoplasmic reticulum kinase to drug resistance of dormant carcinoma cells. Cancer Res 2006; 66: 1702-1711.
Ozcan U, Yilmaz E, Ozcan L, Furuhashi M, Vaillancourt E, Smith RO et al. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 2006; 313: 1137-1140.
Corazzari M. ER stress & autophagy in cancer: Contenders or partners in crime? Int J Mol Biol Biochem 2013; 1: 23.
Lee AS, Hendershot LM. ER stress and cancer. Cancer Biol Ther 2006; 5: 721-722.
Kirkin V, McEwan DG, Novak I, Dikic I. A role for ubiquitin in selective autophagy. Mol Cell 2009; 34: 259-269.
Michaud M, Martins I, Sukkurwala AQ, Adjemian S, Ma Y, Pellegatti P et al. Autophagydependent anticancer immune responses induced by chemotherapeutic agents in mice. Science 2011; 334: 1573-1577.
Rosenfeldt MT, O'Prey J, Morton JP, Nixon C, MacKay G, Mrowinska A et al. P53 status determines the role of autophagy in pancreatic tumour development. Nature 2013; 504: 296-300.
Pagliarini V, Wirawan E, Romagnoli A, Ciccosanti F, Lisi G, Lippens S et al. PMC3422474; proteolysis of Ambra1 during apoptosis has a role in the inhibition of the autophagic prosurvival response. Cell Death Differ 2012; 19: 1495-1504.
Derijard B, Hibi M, Wu IH, Barrett T, Su B, Deng T et al. JNK1: A protein kinase stimulated by UV light and ha-ras that binds and phosphorylates the c-jun activation domain. Cell 1994; 76: 1025-1037.
Enslen H, Raingeaud J, Davis RJ. Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6. J Biol Chem 1998; 273: 1741-1748.
Di Bartolomeo S, Corazzari M, Nazio F, Oliverio S, Lisi G, Antonioli M et al. The dynamic interaction of AMBRA1 with the dynein motor complex regulates mammalian autophagy. J Cell Biol 2010; 191: 155-168.
